Age Guidelines for Starting Antihistamines in Pediatric Patients
Second-generation antihistamines (cetirizine, loratadine) can be safely started at 6 months of age, while first-generation antihistamines like diphenhydramine should be avoided in children under 6 years due to significant safety concerns including risk of fatalities. 1, 2
Age-Specific Antihistamine Recommendations
Infants Under 6 Months
- Antihistamines are not recommended in this age group due to lack of safety data and FDA approval 2
- Between 1969-2006, there were 41 fatalities associated with antihistamines in children under 2 years, highlighting the serious risks in young infants 1, 2
- For allergic symptoms in this age group, intranasal corticosteroids are the most effective first-line treatment, controlling all four major symptoms of allergic rhinitis 2
Infants 6-11 Months
- Cetirizine can be administered at 0.25 mg/kg twice daily (approximately 2.5 mg twice daily for a 10 kg infant) based on controlled safety studies 1, 2
- Loratadine has also been studied in controlled trials down to 6 months of age 1
- This represents the earliest age at which second-generation antihistamines have documented safety profiles 2
Children 2-5 Years
- Cetirizine: 2.5 mg once or twice daily (FDA-approved dosing) 1
- Loratadine: 5 mg once daily (FDA-approved dosing) 1, 3
- These are the only two antihistamines with FDA approval for children under 5 years 1
- Possible sedation may occur with higher than recommended doses, emphasizing the importance of adherence to proper dosing 1
Children 6 Years and Older
- Additional second-generation antihistamines become available, including desloratadine, fexofenadine, and levocetirizine 1
- Intranasal antihistamines (azelastine, olopatadine) are only approved for children 12 years and older 1
Critical Safety Considerations
First-Generation Antihistamines
- The FDA and American Academy of Pediatrics recommend against using first-generation antihistamines (diphenhydramine, chlorphenamine) in children under 6 years due to significant safety concerns 1
- These medications impair CNS function far more commonly than generally realized and should be restricted to two specific situations: severe pruritus requiring sedation, or anaphylaxis requiring intravenous diphenhydramine as adjunctive treatment to epinephrine 4
- In 2007, the FDA's advisory committees recommended that OTC cough and cold medications containing antihistamines no longer be used for children below 6 years of age 2
Special Clinical Scenarios
Anaphylaxis Exception:
- In anaphylaxis, diphenhydramine 1-2 mg/kg (25-50 mg per dose) can be administered parenterally as second-line therapy to epinephrine, never as monotherapy 5
- This represents the only appropriate use of first-generation antihistamines in young children 5, 4
Renal Impairment:
- Cetirizine requires dose reduction in moderate renal impairment and should be avoided in severe renal impairment 2
- This consideration applies once the child reaches appropriate age for antihistamine use 2
Common Pitfalls to Avoid
- Never use intranasal antihistamines in children under 6 years due to lack of FDA approval 1
- Avoid off-label prescribing in children under 2 years, where most safety data are lacking 6
- Do not use first-generation antihistamines for routine allergic symptoms in children under 6 years, despite their widespread historical use and presumed safety 1, 4
- Consult product labeling before prescribing in children under 6 years, as dosing and age restrictions vary significantly between products 2
Alternative Treatment Options for Young Children
When antihistamines are not appropriate or insufficient: